{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:10:55Z","timestamp":1759972255391,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.clineuro.2022.107308","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T11:00:22Z","timestamp":1653735622000},"page":"107308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antithrombotic therapy versus patent foramen ovale closure for PFO-associated stroke"],"prefix":"10.1016","volume":"221","author":[{"given":"Sanaullah","family":"Mojaddedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas","family":"Palaiodimos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad O","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimesh K","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad K","family":"Mojadidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2022.107308_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107189","article-title":"Dabigatran versus aspirin for stroke prevention after cryptogenic stroke with patent foramen ovale: a prospective study","volume":"215","author":"Chen","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clineuro.2022.107308_bib2","doi-asserted-by":"crossref","first-page":"1022e32","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.clineuro.2022.107308_bib3","doi-asserted-by":"crossref","first-page":"1033e42","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.clineuro.2022.107308_bib4","first-page":"2335e42","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clineuro.2022.107308_bib5","doi-asserted-by":"crossref","first-page":"1011e21","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. Antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.clineuro.2022.107308_bib6","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2033779","article-title":"Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke","volume":"384","author":"Kasner","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.clineuro.2022.107308_bib7","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2020.02.068","article-title":"Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale","volume":"75","author":"Turc","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107308_bib8","first-page":"E621","article-title":"A comparison of methods to determine patent foramen ovale size","volume":"96","author":"Kumar","year":"2020","journal-title":"Catheter Cardiovasc Int."},{"issue":"22","key":"10.1016\/j.clineuro.2022.107308_bib9","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2021.20956","article-title":"Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke","volume":"326","author":"Kent","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107308_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2018.05.035","article-title":"Atrial fibrillation after percutaneous patent foramen ovale closure","volume":"122","author":"Mojadidi","year":"2018","journal-title":"Am. J. Cardiol."},{"issue":"17","key":"10.1016\/j.clineuro.2022.107308_bib11","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4244\/EIJ-D-18-00767","article-title":"New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials","volume":"14","author":"Elgendy","year":"2019","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107308_bib12","first-page":"199","article-title":"Interventional PFO closure: what we see is but the tip of the iceberg","volume":"50","author":"Windecker","year":"2000","journal-title":"Catheter Cardiovasc Int."},{"year":"2019","author":"Mojadidi","series-title":"Patent Foramen Ovale Closure for Stroke, Myocardial Infarction, Peripheral Embolism, Migraine, and Hypoxemia","key":"10.1016\/j.clineuro.2022.107308_bib13"},{"key":"10.1016\/j.clineuro.2022.107308_bib14","first-page":"213e20","article-title":"Epidemiology of atrial fibrillation: european perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107308_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.118.021403","article-title":"Letter by Mojadidi et al. Regarding Article \u201cClosure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis\u201d","volume":"49","author":"Mojadidi","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2022.107308_bib16","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","article-title":"Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis","volume":"36","author":"Kent","year":"2015","journal-title":"Eur. Heart J."},{"issue":"20","key":"10.1016\/j.clineuro.2022.107308_bib17","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.clineuro.2022.107308_bib18","first-page":"333","volume":"75","author":"Ntaios","year":"2020","journal-title":"Embolic Stroke Undetermined Source.: JACC Rev. Top. Week"},{"issue":"7","key":"10.1016\/j.clineuro.2022.107308_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023761","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence","volume":"8","author":"Mir","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.clineuro.2022.107308_bib20","doi-asserted-by":"crossref","first-page":"k2515","DOI":"10.1136\/bmj.k2515","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? a clinical practice guideline","volume":"362","author":"Kuijpers","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.clineuro.2022.107308_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jacc.2017.12.059","article-title":"Cryptogenic stroke and patent foramen ovale","volume":"71","author":"Mojadidi","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clineuro.2022.107308_bib22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00392-018-1305-4","article-title":"Patent foramen ovale closure for patients excluded from the randomized cryptogenic stroke trials","volume":"107","author":"Zaman","year":"2018","journal-title":"Clin. Res Cardiol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722001895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722001895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:28:12Z","timestamp":1759955292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722001895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":22,"alternative-id":["S0303846722001895"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107308","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic therapy versus patent foramen ovale closure for PFO-associated stroke","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107308"}}